Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativit
- Research Organization:
- Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- DOE - Office Of Science; National Institutes of Health (NIH)
- OSTI ID:
- 1856408
- Journal Information:
- J. Med. Chem., Vol. 65, Issue (4)
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativit
Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativit
Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti–COVID-19 drug design
Journal Article
·
2022
· J. Med. Chem.
·
OSTI ID:1856408
+10 more
Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativit
Journal Article
·
2022
· J. Med. Chem.
·
OSTI ID:1856408
+10 more
Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti–COVID-19 drug design
Journal Article
·
2020
· Science Advances
·
OSTI ID:1856408
+8 more